SlideShare a Scribd company logo
Unit- I
Introduction to Pharmacology- Part-II
Pharmacokinetics – Absorption, Distribution,
metabolism, excretion
Ms. Kanchan Chouksey
Pharmacy, Medi-caps University, Indore
Email:
BP 404 T Pharmacology I
Ms. Kanchan chouksey
 Unit I a. Introduction to Pharmacology
b. Pharmacokinetics
 Unit II a. Pharmacodynamics,
b. Adverse drug reaction,
c. Drug Interactions
d. Drug discovery and clinical evaluation of new drugs
 Unit III Pharmacology of drugs acting on Peripheral nervous system
 Unit IV Pharmacology of Drugs acting on Central Nervous system
 Unit V Pharmacology of Drugs acting on Central nervous system
Books
Text Books
 K.D. Tripathi A Text book of Pharmacology
 Sparsh gupta A textbook of Pharmacology
Reference Books
 Goodman and Gilman’s A Text book of Pharmacology
 Rang H.P., Dale M.M., A Text book of Pharmacology
 Lippincott A Text book of Pharmacology
Other Books
Sharma H.L. , Sharma K.K., A textbook of Pharmacology,
and many others
Ms. Kanchan chouksey
Receptor :
These are macromolecule or binding site
located on the surface or Inside the cell that
recognise the signal , molecule, or drug and
initiate the response
Ms. Kanchan
chouksey
Agonist & Antagonist
Ms. Kanchan
chouksey
Agonist :
 Agonist facilitate the receptor response.
 An agonist is a mimetic of the natural ligand.
 It produces a similar biological effect as the natural ligand when it binds
to the receptor.
 It binds at the same binding site and leads in the absence of the natural
ligand , to either a full or partial response.
 In the latter case, it is called a partial agonist.
Ms. Kanchan
chouksey
The figure below shows the action of ligand,
agonist, and partial agonist:
Ms. Kanchan
chouksey
Antagonists:
 Antagonist inhibits receptor response.
 As there name implies, an antagonist inhibit the effects of the natural
ligand (hormone, neurotransmitter), agonist, partial agonist, and even
inverse agonists.
Ms. Kanchan
chouksey
Antagonist Types :
 Competitive Antagonist
 Non competitive Antagonist
Ms. Kanchan chouksey
A competitive antagonist binds to the same
site as the agonist but does not activate it,
thus blocks the agonist's action.
A non-competitive antagonist binds to an
allosteric (non-agonist) site on the
receptor to prevent activation of the
receptor.
Mechanism of Ligand, Agonist, Antagonist
Ms. Kanchan chouksey
The following terms are used in describing drug-
receptor interaction:
 Agonist- An agent which activates a receptor to produce an effect similar to that
of the physiological signal molecule.
 Inverse agonist -An agent which activates a receptor to produce an effect in the
opposite direction to that of the agonist.
 Antagonist- An agent which prevents the action of agonist on a receptor or the
subsequent response, but does not have any effect of its own.
Ms. Kanchan chouksey
Continue…
Partial agonist -
 An agent which activates a receptor to produce submaximal effect but
antagonizes the action of a full agonist.
Ligand -
 Any molecule which attaches selectively to particular receptors or sites.
 The term only indicates affinity or ability to bind without regard to functional
change: agonists and competitive antagonist are both ligands of the same receptor.
Ms. Kanchan chouksey
Graded dose–response relations
Ms. Kanchan
chouksey
 As the concentration of a drug increases, its pharmacologic
effect also gradually increases until all the receptors are
occupied (the maximum effect).
 It is used to determine affinity, potency, efficacy
Affinity:
 A drug's affinity refers to the chemical forces that cause a substance to
bind its receptor.
 Intrinsic activity is a measure of the ability of a drug that is bound to
the receptor to generate an activating stimulus and produce a change
in cellular activity.
 Both agonists and antagonists can bind to a receptor.
Ms. Kanchan
chouksey
Continue…
Ms. Kanchan
chouksey
Potency :
Effective concentration (EC50) is the concentration of an agonist needed
to elicit half of the maximum biological response of the agonist.
Ms. Kanchan
chouksey
E.g., Highly potent drug -
fentanyl, alprazolam , evokes a
given response at low
concentrations
while a drug of
lower potency like diazepam,
ziprasidone, evokes the same
response only at higher
concentrations
Efficacy:
Efficacy is a drug's capacity to produce an effect
Ms. Kanchan
chouksey
E.g.-
1. Diuretic drugs : Furosemide
eliminates much more salt and
water through urine than
hydrochlorothiazide.
2. Analgesics : aspirin is less potent
as well as less efficacious than
Morphine
3. Sedative : Diazepam is less
efficacious than pentobarbitone
Drug Dependence, Tolerance & Addiction
Ms. Kanchan
chouksey
Drug Tolerance :
Ms. Kanchan
chouksey
 It refers to the requirement of higher dose of a drug to produce a given
response.
 Loss of therapeutic efficacy after prolonged/intensive use of a drug.
 Like sulfonylureas in type 2 diabetes , Beta-2 agonists in bronchial
asthma
 Example : Before X drug 500 mg Response
Tolerance 800mg Response
Drug tolerance may be:
Natural
 The species/individual is inherently less sensitive to the drug.
E.g. rabbits are tolerant to atropine, Hyporesponsive people for Beta blocker.
Ms. Kanchan
chouksey
Acquired :
 This is a result of repeated use of drug in an individual was initially responsive for
the same drug.
 Body is capable of developing tolerance to most drugs, but the phenomenon is very
easily recognized in the case of CNS depressants.
 E.g.:
• CNS Depressant – like chlorpromazine ( sedative action ), Analgesics (Morphine) ,
Alcohol
Note : Higher dose is required for the effect of the same drug
Ms. Kanchan
chouksey
Cross tolerance
 One drug causes tolerance to other given drug but only when both has same
pharmacological activity
 It is the development of tolerance to pharmacologically related drugs
E.g.- alcoholics are relatively tolerant to barbiturates and general
anaesthetics
Why ?
Because frequent consumption of alcohol develops tolerance for
Barbiturates and General anesthetics ( Higher dose is required )
Ms. Kanchan
chouksey
Drug dependence :
 It is an altered physiological state produced by repeated administration of a
drug which necessitates the continued presence of the drug to maintain
physiological equilibrium.
 This has been earlier termed 'physical dependence’ but is now simply called
'dependence '
Ms. Kanchan
chouksey
Continue…
 This is due to adaptation of the nervous system to function normally in the
presence of the drug, it has been also called 'neuroadaptation' .
 Drugs producing dependence are - opioids, barbiturates, alcohol
 Opioid dependence causes withdrawal symptoms, which makes it difficult to
stop taking them.
Ms. Kanchan
chouksey
Drug addiction
Ms. Kanchan
chouksey
 A person is said to have developed 'drug addiction' when he/she believes
that optimal state of well being is achieved only through the actions or
the drug.
 The subject feels emotionally distressed if the drug is not taken.
 It often starts as liking for the drug effects and progresses to compulsive
drug use in some individuals who lose control and cannot stop taking the
drug, even if they known it to be harmful.
Continue…
 This was earlier termed 'psychological dependence'.
 However, to avoid confusion, the widely understood term 'drug addiction' is
used now.
 Drug addiction is a pattern of compulsive drug use characterized by
overwhelming involvement with the use of a drug.
 Amphetamines, cocaine, are CNS stimulants drugs which produce
addiction but Little/no dependence.
 Results : Feeling happy, Sexual arousal , fast heart beat , pupil dilation
Ms. Kanchan
chouksey
Tachyphylaxis
Ms. Kanchan
chouksey
 When some drugs administered repeatedly at short intervals, the cell
receptors get blocked up and pharmacological response to that drug
decreased.
 The decreased response cannot be reversed by increasing the dose this
phenomenon is called tachyphylaxis or acute tolerance
 E.g. ephedrine given repeated dose at short intervals in the treatment
of bronchial asthma may produce very less response due to
tachyphylaxis
Idiosyncrasy-
Ms. Kanchan chouksey
 Non-immunological hypersenstivity of drug in specific individual without
connection to pharmacological toxicity.
 Idiosyncrasy refers to genetically determined abnormal reactivity to a chemical.
 Idiosyncrasy is also called as allergy.
 An extraordinary response to a drug which is different from its characteristic
pharmacological action is called idiosyncrasy.
 E.g. small quantity of aspirin may cause gastric hemorrhage.
 E.g. some persons are sensitive to penicillin and sulphonamide because they
produce severe toxic effect.
Drug allergy (hypersensitivity)
 It is an immunologically mediated reaction.
 The symptoms may appear even with much smaller doses and have a
different time course of onset and duration.
 This is also called drug hypersensitivity.
 The target organs primarily affected in drug allergy are skin, airways, blood
vessels, blood cells and gastrointestinal tract.
Ms. Kanchan
chouksey
Continue…
 The drug or its metabolite acts as an antigen (AG)
 They induce production of antibody (AB)/sensitized lymphocytes.
 A particular drug can produce different types of allergic reactions in different
individuals, while widely different drugs can produce similar reaction.
 Example : Penicillin causes anaphylaxis, methyldopa cause hemolytic
anemia
Ms. Kanchan
chouksey
Continue…
Ms. Kanchan
chouksey
Pharmacokinetics (The life cycle of a Drug)
 Pharmacokinetics is the quantitative study of drug movement in,
through and out of the body.
 Pharmacokinetics: Pharmakon - drug and Kinesis - motion
 The intensity of response is related to concentration of the drug at
the site of action.
 Pharmacokinetic - determine four pharmacokinetic properties determine
the onset, intensity & duration of drug action.
Ms. Kanchan chouksey
Pharmacokinetics :
Ms. Kanchan
chouksey
Continue…
Ms. Kanchan
chouksey
Pharmacokinetics: Membrane Transport, Absorption
and Distribution of Drugs
All pharmacokinetic processes involve transport of the drug across biological
membranes.
Biological membrane:
Ms. Kanchan chouksey
Biological membrane:
Ms. Kanchan
chouksey
 Biological membranes carry out functions that are indispensable for life.
 They provide a barrier against the extracellular environment.
 They also give shape to the cell, creating a matrix for insertion of proteins,
storing and transmitting energy, receiving and amplifying signals,
Structure of Biological membrane Composition:
Ms. Kanchan
chouksey
Biological membrane Composition:
Ms. Kanchan
chouksey
All Biological membrane are composed of mainly lipid and protein
molecule:
Three major types of lipids in cell membrane are:
 Phospholipid -The most abundant.
 Cholesterol- responsible for stabilizing the membrane.
 Glycolipid- found at the external surface of the membrane.
Membrane transport :
Ms. Kanchan
chouksey
Membrane transport of drugs/nutrients :
Ms. Kanchan
chouksey
Continue…
 All of the lipids are described as being amphipathic as they have a
hydrophilic (water- loving) end and a hydrophobic (water-hating) end to
the molecule.
 The proteins within the membrane are largely concerned with the
transport of molecules across the membrane.
Ms. Kanchan
chouksey
Continue…
Drugs are transported across the membranes by:
(a) Passive diffusion
(b) filtration : for low molecular weight ( less than 100)
(c) Specialized transport
(d) Active transport
Ms. Kanchan
chouksey
Passive diffusion:
 The drug diffuses across the membrane in the direction of its concentration
gradient (high to low).
 The membrane playing no active role in the process.
 This is the most important mechanism for majority o f drugs.
 The drugs moves from high concentration to low concentration untill the
equilibrium is maintained between extracellular and intracellular fluid
 It does not require energy and depends on concentration.
Ms. Kanchan
chouksey
Ms. Kanchan
chouksey
Continue…
Ms. Kanchan
chouksey
Continue…
 Lipid soluble drugs diffuse by dissolving in the lipoidal matrix of the
membrane the rate of transport being proportional to the lipid
 Water partition coefficient of the drug.
 A more lipid-soluble drug attains higher concentration in the membrane and
diffuses quickly.
 Also, greater the difference in the concentration of the drug on the two sides of
the membrane, faster is its diffusion.
Ms. Kanchan
chouksey
Continue..
b) Filtration : for molecule of low molecular weight (less than 100) through 7 Å pores of membrane
(1micrometer = 10000 Aangstrom)
Example : Urea , ethylene glycol (additives)
c) Bulk flow : Passage across capillary wall which pore size of 40Å.
d)Active transport:
 Require energy (ATP)
 It work against concentration gradient ( Higher to lower concentration)
 Example : Methyldopa, Levodopa
e) Facilitated diffusion : through carrier proteins
f) Endocystosis ( outside to inside) and exocytosis( Inside to outside) through pinocytosis, phagocytosis
Ms. Kanchan
chouksey
Active transport :
Ms. Kanchan
chouksey
Ms. Kanchan
chouksey
Filtration
 Filtration is passage of drugs through aqueous pores in the membrane or
through paracellular spaces.
 This can be accelerated if hydrodynamic flow of the solvent is occurring under
hydrostatic or osmotic pressure gradient, e.g. across most capillaries including
glomeruli.
Ms. Kanchan
chouksey
Specialized transport
 This can be carrier mediated or by vesicular transport.
 Endocytosis & Exocytosis-
Ms. Kanchan
chouksey
ABSORPTION
 Absorption is the transfer of a drug from the site of administration to the
bloodstream.
 The rate and extent of absorption depend on the environment where the drug
is absorbed, chemical characteristics of the drug, and the route of
administration (which influences bioavailability).
 Routes of administration other than intravenous may result in partial
absorption and lower bioavailability
Ms. Kanchan chouksey
Factors influencing drug absorption:
 Lipid solubility of drug
 pH of the medium ( stomach & intestine)
 pKa of the drug
Ms. Kanchan
chouksey
Lipid solubility of the drug
 Drugs which are lipophilic easily cross the membrane
 Drugs which are lipophobic / Hydrophilic have problem crossing membrane
 This is the major source of variation in drug diffusion or absorption
 Only non ionized drug ( non-polar) diffuse across the cell membrane
 Non polar drugs are lipid soluble
 Polar drugs are water soluble , they cannot absorbs biological membrane
 Lipid soluble = Non ionized molecule( NaCl)
 Hydrophillic = Ionized molecule (Na+, Cl-)
Ms. Kanchan
chouksey
Effect of pH on drug absorption :
Ms. Kanchan
chouksey
 Acidic drug better absorbed in acidic media.
 Basic drug better absorbed in basic media.
 Acidic drugs ( aspirin) are better absorbed in stomach in acidic media.
 Basic drugs better absorbed in intestine ( alkaline media).
Bioavailability
 Bioavailability is the rate and extent to which an administered drug reaches
the systemic circulation.
 Or Bioavailability is the rate and extent of drug absorbs from its dosage form
that reach to the systemic circulation.
 For example, if 100 mg of a drug is administered orally and 70 mg is absorbed
unchanged, the bioavailability is 70%.
Ms. Kanchan
chouksey
Objectives of Bioavailability studies:
Ms. Kanchan
chouksey
 Primary stages of development of a suitable dosage form
 Determination of influence of excipients (Stability and
solubility) and interaction with other drugs on the
efficiency of absorption
Factors affect Bioavailability:
Ms. Kanchan
chouksey
First-pass hepatic metabolism:
 When a drug is absorbed from the GI tract, it enters the portal circulation
before entering the systemic circulation.
 If the drug is rapidly metabolized in the liver or GIT wall during this initial
passage, the amount of unchanged drug entering the systemic circulation is
decreased.
 This is referred to as first-pass metabolism.
 Cytochrome P-450 enzymes metabolized many drugs.
Ms. Kanchan
chouksey
Continue…
Ms. Kanchan
chouksey
Continue…
 First-pass metabolism by the intestine or liver limits the efficacy of many oral
medications.
 For example, more than 90% of nitroglycerin (HF, HBP) is cleared during
first-pass metabolism.
 Hence, it is primarily administered via the sublingual or transdermal route
 Drugs with high first-pass metabolism should be given in doses sufficient
to ensure that enough active drug reaches the desired site of action.
Ms. Kanchan
chouksey
DISTRIBUTION
Drug distribution is the process by which a drug reversibly leaves the bloodstream and
enters the extracellular fluid and the tissues.
Phases of distribution:
First phase :
 Reflect cardiac output and blood flow –
 Thus heart , liver, kidney, and brain receive most of the drugs during the first few
minutes after absorption
Second phase:
 Deliver to muscle, skin, adipose is slower and involves a far large fraction of the
body mass.
Ms. Kanchan
chouksey
Drug reservoirs:
Body compartment where a drug can accumulate are reservoirs and have
dynamic effect on drug availability
1. Plasma proteins (albumins) as reservoirs (bind drug)
2. Cellular reservoirs:
 Adipose (lipophillic drug)
 Bone ( crystal )
Ms. Kanchan
chouksey
Drug Distribution:
Ms. Kanchan
chouksey
Drugs Binding primarily to albumin
Ms. Kanchan
chouksey
 Barbiturates
 Benzodiazepines
 Digitoxin
 Penicillins
 Streptomycin
 sulphonamindes
Volume of distribution:
 The volume of distribution Vd - is defined as the fluid
volume that is required to contain the entire drug in the
body at the same concentration measured in the plasma.
Ms. Kanchan
chouksey
Volume of distribution :
Ms. Kanchan
chouksey
Volume of distribution :
Ms. Kanchan
chouksey
100 mg
water
Vd= Amount of drug given
in body / Concentration of
drug in plasma
Vd= 100/20= 5 L
20mg / L
Concentration = Weight /
volume ( mg / L)
Ms. Kanchan
chouksey
 Drug metabolism is the term used to describe the
biotransformation of pharmaceutical substances in
the body so that they can be eliminated more easily.
 It is the enzymatic conversion from one chemical form of
a substance to another.
 Metabolism is an essential pharmacokinetic process
which converts lipid soluble or non-polar compounds to
water soluble or polar compounds that they are excreted
by various processes.
Metabolism or Biotransformation:
Phases of Metabolism
 Phase I: Non-synthetic reactions such as cleavage (e.g. oxidation,
reduction, hydrolysis), formation or modification of a function group.
 Phase II: Synthetic reactions such as conjugation with an endogenous
substance (e.g. sulfate, glycine, glucuronic acid).
Examples:
 Oxidation – phenytoin, barbiturates
 Hydrolysis- Aspirin
 Reduction- Benzodiazepines
Ms. Kanchan
chouksey
Drug metabolism pathway :
Ms. Kanchan
chouksey
Ms. Kanchan
chouksey
Phase I and Phase II enzymes:
Phase I enzymes:
 Cytochrome P450, Esterase, Alcohol dehydrogenase
,Monoamine oxidase
Phase II enzymes:
 Uridine Diphosphate-glucuronosyl transferase (UDPGT)
(Catalyse the covalent addition of glucuronic acid with lipophilic
chemicals)
 Sulfo transferase ( sulphonation increases water solublity of
lipophilic drugs)
Ms. Kanchan
chouksey
Metabolic enzyme:
Ms. Kanchan
chouksey
Microsomal enzyme
 Found in smooth endoplasmic reticulum of liver cells.
 Example: CYP- 450, mono oxygenase
Non- microsomal enzymes:
 Found in cytoplasm and mitochondria of liver cells.
 Example: Alcholol dehydrogenase,
Excretion :
Ms. Kanchan
chouksey
Drugs and their metabolites are excreted in:
1. Urine –
 Drug excretion in urine occurs via the kidney.
 It is the most important channel of excretion for majority of drugs.
2. Faeces –
 Apart from the unabsorbed fraction, most of the drug present in faeces is
derived from bile.
 Liver actively transports into bile organic acids
Ms. Kanchan
chouksey
Continue..
3. Milk –
 The excretion or drug in milk is not important for the mother.
 Most drugs enter breast milk by passive diffusion.
 As such. more lipid soluble and less protein bound drugs cross better.
 Milk has a lower pH (7.0) than plasma, basic drugs are somewhat more concentrated
in it.
Ms. Kanchan
chouksey
Enzyme Inducers and Enzyme inhibitors :
Ms. Kanchan
chouksey
Kinetics of drug metabolism and elimination:
Ms. Kanchan
chouksey
Continue…
Ms. Kanchan
chouksey
Questions
Ms. Kanchan chouksey
Ms. Kanchan
chouksey
Thank You
Great God, Medi-Caps, All the attendees
Ms. Kanchan chouksey
Ms. Kanchan chouksey

More Related Content

What's hot

Drugs used in Parkinsonism
Drugs used in Parkinsonism Drugs used in Parkinsonism
Drugs used in Parkinsonism
Talha Yousuf
 
Serotonin Pharmacology (5-HT) [Neurotransmitter]
Serotonin Pharmacology (5-HT) [Neurotransmitter]Serotonin Pharmacology (5-HT) [Neurotransmitter]
Serotonin Pharmacology (5-HT) [Neurotransmitter]
Megh Vithalkar
 
2.2.1 neurohumoral transmission
2.2.1 neurohumoral transmission2.2.1 neurohumoral transmission
2.2.1 neurohumoral transmission
Arunachalam Muthuraman
 
Parasympathomimetics
ParasympathomimeticsParasympathomimetics
Parasympathomimetics
AnkurJoshi62
 
CHOLINERGIC AGONISTS
CHOLINERGIC AGONISTSCHOLINERGIC AGONISTS
CHOLINERGIC AGONISTS
kencha swathi
 
Cholinergic receptors,funtion and its clinical application
Cholinergic receptors,funtion and its clinical applicationCholinergic receptors,funtion and its clinical application
Cholinergic receptors,funtion and its clinical application
Dr.UMER SUFYAN M
 
Sympatholytic drug
Sympatholytic drugSympatholytic drug
Sympatholytic drug
tushardhote1
 
Receptor ppt
Receptor pptReceptor ppt
Receptor ppt
RakeshAmrutkar
 
Neurohumoral Transmission in CNS
Neurohumoral Transmission in CNSNeurohumoral Transmission in CNS
Neurohumoral Transmission in CNS
Raveena Chauhan
 
Organisation of ans
Organisation of ansOrganisation of ans
Organisation of ans
Smita Jain
 
Drugs acting on the cns
Drugs acting on the cnsDrugs acting on the cns
Drugs acting on the cns
Bruno Mmassy
 
Pharmacology-I_sem-4_RDP lab manual
Pharmacology-I_sem-4_RDP lab manualPharmacology-I_sem-4_RDP lab manual
Pharmacology-I_sem-4_RDP lab manual
rishi2789
 
Serotonin pharmacology
Serotonin  pharmacologySerotonin  pharmacology
Serotonin pharmacology
AliLaith5230
 
Anticonvulsant effect of drugs by MES and PTZ method
Anticonvulsant effect of drugs by MES and PTZ methodAnticonvulsant effect of drugs by MES and PTZ method
Anticonvulsant effect of drugs by MES and PTZ method
MirzaAnwarBaig1
 
Medicinal chemistry -l-Second year-Fourth semester -medichem intro and histor...
Medicinal chemistry -l-Second year-Fourth semester -medichem intro and histor...Medicinal chemistry -l-Second year-Fourth semester -medichem intro and histor...
Medicinal chemistry -l-Second year-Fourth semester -medichem intro and histor...
manjusha kareppa
 
Parasympathomimetic agents
Parasympathomimetic agentsParasympathomimetic agents
Parasympathomimetic agents
Kirti Vadi
 
Pharmacology neuromuscular blockers & anemia
Pharmacology   neuromuscular blockers & anemiaPharmacology   neuromuscular blockers & anemia
Pharmacology neuromuscular blockers & anemia
MBBS IMS MSU
 
1. agonist and antagonist
1. agonist and antagonist1. agonist and antagonist
1. agonist and antagonist
Sohan Patel
 
Neurotransmitters in CNS
Neurotransmitters in CNSNeurotransmitters in CNS
Neurotransmitters in CNS
Subramani Parasuraman
 
BP 602 Pharmacology of drugs acting on Respiratory system.pdf
BP 602 Pharmacology of drugs acting on Respiratory system.pdfBP 602 Pharmacology of drugs acting on Respiratory system.pdf
BP 602 Pharmacology of drugs acting on Respiratory system.pdf
Vikas Kumar Jain
 

What's hot (20)

Drugs used in Parkinsonism
Drugs used in Parkinsonism Drugs used in Parkinsonism
Drugs used in Parkinsonism
 
Serotonin Pharmacology (5-HT) [Neurotransmitter]
Serotonin Pharmacology (5-HT) [Neurotransmitter]Serotonin Pharmacology (5-HT) [Neurotransmitter]
Serotonin Pharmacology (5-HT) [Neurotransmitter]
 
2.2.1 neurohumoral transmission
2.2.1 neurohumoral transmission2.2.1 neurohumoral transmission
2.2.1 neurohumoral transmission
 
Parasympathomimetics
ParasympathomimeticsParasympathomimetics
Parasympathomimetics
 
CHOLINERGIC AGONISTS
CHOLINERGIC AGONISTSCHOLINERGIC AGONISTS
CHOLINERGIC AGONISTS
 
Cholinergic receptors,funtion and its clinical application
Cholinergic receptors,funtion and its clinical applicationCholinergic receptors,funtion and its clinical application
Cholinergic receptors,funtion and its clinical application
 
Sympatholytic drug
Sympatholytic drugSympatholytic drug
Sympatholytic drug
 
Receptor ppt
Receptor pptReceptor ppt
Receptor ppt
 
Neurohumoral Transmission in CNS
Neurohumoral Transmission in CNSNeurohumoral Transmission in CNS
Neurohumoral Transmission in CNS
 
Organisation of ans
Organisation of ansOrganisation of ans
Organisation of ans
 
Drugs acting on the cns
Drugs acting on the cnsDrugs acting on the cns
Drugs acting on the cns
 
Pharmacology-I_sem-4_RDP lab manual
Pharmacology-I_sem-4_RDP lab manualPharmacology-I_sem-4_RDP lab manual
Pharmacology-I_sem-4_RDP lab manual
 
Serotonin pharmacology
Serotonin  pharmacologySerotonin  pharmacology
Serotonin pharmacology
 
Anticonvulsant effect of drugs by MES and PTZ method
Anticonvulsant effect of drugs by MES and PTZ methodAnticonvulsant effect of drugs by MES and PTZ method
Anticonvulsant effect of drugs by MES and PTZ method
 
Medicinal chemistry -l-Second year-Fourth semester -medichem intro and histor...
Medicinal chemistry -l-Second year-Fourth semester -medichem intro and histor...Medicinal chemistry -l-Second year-Fourth semester -medichem intro and histor...
Medicinal chemistry -l-Second year-Fourth semester -medichem intro and histor...
 
Parasympathomimetic agents
Parasympathomimetic agentsParasympathomimetic agents
Parasympathomimetic agents
 
Pharmacology neuromuscular blockers & anemia
Pharmacology   neuromuscular blockers & anemiaPharmacology   neuromuscular blockers & anemia
Pharmacology neuromuscular blockers & anemia
 
1. agonist and antagonist
1. agonist and antagonist1. agonist and antagonist
1. agonist and antagonist
 
Neurotransmitters in CNS
Neurotransmitters in CNSNeurotransmitters in CNS
Neurotransmitters in CNS
 
BP 602 Pharmacology of drugs acting on Respiratory system.pdf
BP 602 Pharmacology of drugs acting on Respiratory system.pdfBP 602 Pharmacology of drugs acting on Respiratory system.pdf
BP 602 Pharmacology of drugs acting on Respiratory system.pdf
 

Similar to UNIT I Part 2&3.pptx

Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
BikashAdhikari26
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
A M O L D E O R E
 
Pharmacodynamics
Pharmacodynamics Pharmacodynamics
Pharmacodynamics
OPTOM FASLU MUHAMMED
 
Chapter 5 Psychopharmacology And New Drug Development
Chapter 5   Psychopharmacology And New Drug DevelopmentChapter 5   Psychopharmacology And New Drug Development
Chapter 5 Psychopharmacology And New Drug Development
Justin Gatewood
 
Mechanism of drug action & factor modifying drug action
Mechanism of drug action & factor modifying drug actionMechanism of drug action & factor modifying drug action
Mechanism of drug action & factor modifying drug action
Dipak Bari
 
PHARMACOLGY I-Lecturer 1.pptx
PHARMACOLGY I-Lecturer 1.pptxPHARMACOLGY I-Lecturer 1.pptx
PHARMACOLGY I-Lecturer 1.pptx
KeyaArere
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
Al Riyad Hasan
 
Drug abuse and addiction 2015
Drug  abuse and addiction  2015Drug  abuse and addiction  2015
Drug abuse and addiction 2015
lateef khan
 
Pharmacodynamics.ppt
Pharmacodynamics.pptPharmacodynamics.ppt
Pharmacodynamics.ppt
NuhuUsman1
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
ayman255825
 
Pharmacodynamics.ppthhhhhhhhhhhghhghhhhhhh
Pharmacodynamics.ppthhhhhhhhhhhghhghhhhhhhPharmacodynamics.ppthhhhhhhhhhhghhghhhhhhh
Pharmacodynamics.ppthhhhhhhhhhhghhghhhhhhh
DRSURYANITHISHMANICK
 
Psychopharmacology
Psychopharmacology Psychopharmacology
Psychopharmacology
Lenie Rose Julia
 
3 - Lec - Pahrma.pdf
3 - Lec - Pahrma.pdf3 - Lec - Pahrma.pdf
3 - Lec - Pahrma.pdf
OPTOM Nimra Murtaza
 
Introduction of Pharma post rn.pptx
Introduction of Pharma post rn.pptxIntroduction of Pharma post rn.pptx
Introduction of Pharma post rn.pptx
PATNIHUSAINIBLOODBAN
 
Posology.pptx
Posology.pptxPosology.pptx
Posology.pptx
Archana736307
 
Dental Pharmacology- Pharmacodynamic
Dental Pharmacology- PharmacodynamicDental Pharmacology- Pharmacodynamic
Dental Pharmacology- Pharmacodynamic
Taha Hussein Kadi
 
Pharma 2012 introduction lec 1 final 2012
Pharma 2012 introduction lec 1 final 2012Pharma 2012 introduction lec 1 final 2012
Pharma 2012 introduction lec 1 final 2012
Beth Villanueva Rey Matias
 
Pharmacodynamics revised
Pharmacodynamics   revisedPharmacodynamics   revised
Pharmacodynamics revised
Omar Moatamed
 
pharmacodynamics.pptx
pharmacodynamics.pptxpharmacodynamics.pptx
pharmacodynamics.pptx
Aishwarya Sinha
 
The Pharmacological Intervention in Drug and Alcohol Addiction
The Pharmacological Intervention in Drug and Alcohol AddictionThe Pharmacological Intervention in Drug and Alcohol Addiction
The Pharmacological Intervention in Drug and Alcohol Addiction
Colleen Farrelly
 

Similar to UNIT I Part 2&3.pptx (20)

Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Pharmacodynamics
Pharmacodynamics Pharmacodynamics
Pharmacodynamics
 
Chapter 5 Psychopharmacology And New Drug Development
Chapter 5   Psychopharmacology And New Drug DevelopmentChapter 5   Psychopharmacology And New Drug Development
Chapter 5 Psychopharmacology And New Drug Development
 
Mechanism of drug action & factor modifying drug action
Mechanism of drug action & factor modifying drug actionMechanism of drug action & factor modifying drug action
Mechanism of drug action & factor modifying drug action
 
PHARMACOLGY I-Lecturer 1.pptx
PHARMACOLGY I-Lecturer 1.pptxPHARMACOLGY I-Lecturer 1.pptx
PHARMACOLGY I-Lecturer 1.pptx
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Drug abuse and addiction 2015
Drug  abuse and addiction  2015Drug  abuse and addiction  2015
Drug abuse and addiction 2015
 
Pharmacodynamics.ppt
Pharmacodynamics.pptPharmacodynamics.ppt
Pharmacodynamics.ppt
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
Pharmacodynamics.ppthhhhhhhhhhhghhghhhhhhh
Pharmacodynamics.ppthhhhhhhhhhhghhghhhhhhhPharmacodynamics.ppthhhhhhhhhhhghhghhhhhhh
Pharmacodynamics.ppthhhhhhhhhhhghhghhhhhhh
 
Psychopharmacology
Psychopharmacology Psychopharmacology
Psychopharmacology
 
3 - Lec - Pahrma.pdf
3 - Lec - Pahrma.pdf3 - Lec - Pahrma.pdf
3 - Lec - Pahrma.pdf
 
Introduction of Pharma post rn.pptx
Introduction of Pharma post rn.pptxIntroduction of Pharma post rn.pptx
Introduction of Pharma post rn.pptx
 
Posology.pptx
Posology.pptxPosology.pptx
Posology.pptx
 
Dental Pharmacology- Pharmacodynamic
Dental Pharmacology- PharmacodynamicDental Pharmacology- Pharmacodynamic
Dental Pharmacology- Pharmacodynamic
 
Pharma 2012 introduction lec 1 final 2012
Pharma 2012 introduction lec 1 final 2012Pharma 2012 introduction lec 1 final 2012
Pharma 2012 introduction lec 1 final 2012
 
Pharmacodynamics revised
Pharmacodynamics   revisedPharmacodynamics   revised
Pharmacodynamics revised
 
pharmacodynamics.pptx
pharmacodynamics.pptxpharmacodynamics.pptx
pharmacodynamics.pptx
 
The Pharmacological Intervention in Drug and Alcohol Addiction
The Pharmacological Intervention in Drug and Alcohol AddictionThe Pharmacological Intervention in Drug and Alcohol Addiction
The Pharmacological Intervention in Drug and Alcohol Addiction
 

Recently uploaded

Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdfHiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdf
Dr. Sujit Chatterjee CEO Hiranandani Hospital
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 

Recently uploaded (20)

Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdfHiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 

UNIT I Part 2&3.pptx

  • 1. Unit- I Introduction to Pharmacology- Part-II Pharmacokinetics – Absorption, Distribution, metabolism, excretion Ms. Kanchan Chouksey Pharmacy, Medi-caps University, Indore Email:
  • 2. BP 404 T Pharmacology I Ms. Kanchan chouksey  Unit I a. Introduction to Pharmacology b. Pharmacokinetics  Unit II a. Pharmacodynamics, b. Adverse drug reaction, c. Drug Interactions d. Drug discovery and clinical evaluation of new drugs  Unit III Pharmacology of drugs acting on Peripheral nervous system  Unit IV Pharmacology of Drugs acting on Central Nervous system  Unit V Pharmacology of Drugs acting on Central nervous system
  • 3. Books Text Books  K.D. Tripathi A Text book of Pharmacology  Sparsh gupta A textbook of Pharmacology Reference Books  Goodman and Gilman’s A Text book of Pharmacology  Rang H.P., Dale M.M., A Text book of Pharmacology  Lippincott A Text book of Pharmacology Other Books Sharma H.L. , Sharma K.K., A textbook of Pharmacology, and many others Ms. Kanchan chouksey
  • 4. Receptor : These are macromolecule or binding site located on the surface or Inside the cell that recognise the signal , molecule, or drug and initiate the response Ms. Kanchan chouksey
  • 5. Agonist & Antagonist Ms. Kanchan chouksey
  • 6. Agonist :  Agonist facilitate the receptor response.  An agonist is a mimetic of the natural ligand.  It produces a similar biological effect as the natural ligand when it binds to the receptor.  It binds at the same binding site and leads in the absence of the natural ligand , to either a full or partial response.  In the latter case, it is called a partial agonist. Ms. Kanchan chouksey
  • 7. The figure below shows the action of ligand, agonist, and partial agonist: Ms. Kanchan chouksey
  • 8. Antagonists:  Antagonist inhibits receptor response.  As there name implies, an antagonist inhibit the effects of the natural ligand (hormone, neurotransmitter), agonist, partial agonist, and even inverse agonists. Ms. Kanchan chouksey
  • 9. Antagonist Types :  Competitive Antagonist  Non competitive Antagonist Ms. Kanchan chouksey A competitive antagonist binds to the same site as the agonist but does not activate it, thus blocks the agonist's action. A non-competitive antagonist binds to an allosteric (non-agonist) site on the receptor to prevent activation of the receptor.
  • 10. Mechanism of Ligand, Agonist, Antagonist Ms. Kanchan chouksey
  • 11. The following terms are used in describing drug- receptor interaction:  Agonist- An agent which activates a receptor to produce an effect similar to that of the physiological signal molecule.  Inverse agonist -An agent which activates a receptor to produce an effect in the opposite direction to that of the agonist.  Antagonist- An agent which prevents the action of agonist on a receptor or the subsequent response, but does not have any effect of its own. Ms. Kanchan chouksey
  • 12. Continue… Partial agonist -  An agent which activates a receptor to produce submaximal effect but antagonizes the action of a full agonist. Ligand -  Any molecule which attaches selectively to particular receptors or sites.  The term only indicates affinity or ability to bind without regard to functional change: agonists and competitive antagonist are both ligands of the same receptor. Ms. Kanchan chouksey
  • 13. Graded dose–response relations Ms. Kanchan chouksey  As the concentration of a drug increases, its pharmacologic effect also gradually increases until all the receptors are occupied (the maximum effect).  It is used to determine affinity, potency, efficacy
  • 14. Affinity:  A drug's affinity refers to the chemical forces that cause a substance to bind its receptor.  Intrinsic activity is a measure of the ability of a drug that is bound to the receptor to generate an activating stimulus and produce a change in cellular activity.  Both agonists and antagonists can bind to a receptor. Ms. Kanchan chouksey
  • 16. Potency : Effective concentration (EC50) is the concentration of an agonist needed to elicit half of the maximum biological response of the agonist. Ms. Kanchan chouksey E.g., Highly potent drug - fentanyl, alprazolam , evokes a given response at low concentrations while a drug of lower potency like diazepam, ziprasidone, evokes the same response only at higher concentrations
  • 17. Efficacy: Efficacy is a drug's capacity to produce an effect Ms. Kanchan chouksey E.g.- 1. Diuretic drugs : Furosemide eliminates much more salt and water through urine than hydrochlorothiazide. 2. Analgesics : aspirin is less potent as well as less efficacious than Morphine 3. Sedative : Diazepam is less efficacious than pentobarbitone
  • 18. Drug Dependence, Tolerance & Addiction Ms. Kanchan chouksey
  • 19. Drug Tolerance : Ms. Kanchan chouksey  It refers to the requirement of higher dose of a drug to produce a given response.  Loss of therapeutic efficacy after prolonged/intensive use of a drug.  Like sulfonylureas in type 2 diabetes , Beta-2 agonists in bronchial asthma  Example : Before X drug 500 mg Response Tolerance 800mg Response
  • 20. Drug tolerance may be: Natural  The species/individual is inherently less sensitive to the drug. E.g. rabbits are tolerant to atropine, Hyporesponsive people for Beta blocker. Ms. Kanchan chouksey
  • 21. Acquired :  This is a result of repeated use of drug in an individual was initially responsive for the same drug.  Body is capable of developing tolerance to most drugs, but the phenomenon is very easily recognized in the case of CNS depressants.  E.g.: • CNS Depressant – like chlorpromazine ( sedative action ), Analgesics (Morphine) , Alcohol Note : Higher dose is required for the effect of the same drug Ms. Kanchan chouksey
  • 22. Cross tolerance  One drug causes tolerance to other given drug but only when both has same pharmacological activity  It is the development of tolerance to pharmacologically related drugs E.g.- alcoholics are relatively tolerant to barbiturates and general anaesthetics Why ? Because frequent consumption of alcohol develops tolerance for Barbiturates and General anesthetics ( Higher dose is required ) Ms. Kanchan chouksey
  • 23. Drug dependence :  It is an altered physiological state produced by repeated administration of a drug which necessitates the continued presence of the drug to maintain physiological equilibrium.  This has been earlier termed 'physical dependence’ but is now simply called 'dependence ' Ms. Kanchan chouksey
  • 24. Continue…  This is due to adaptation of the nervous system to function normally in the presence of the drug, it has been also called 'neuroadaptation' .  Drugs producing dependence are - opioids, barbiturates, alcohol  Opioid dependence causes withdrawal symptoms, which makes it difficult to stop taking them. Ms. Kanchan chouksey
  • 25. Drug addiction Ms. Kanchan chouksey  A person is said to have developed 'drug addiction' when he/she believes that optimal state of well being is achieved only through the actions or the drug.  The subject feels emotionally distressed if the drug is not taken.  It often starts as liking for the drug effects and progresses to compulsive drug use in some individuals who lose control and cannot stop taking the drug, even if they known it to be harmful.
  • 26. Continue…  This was earlier termed 'psychological dependence'.  However, to avoid confusion, the widely understood term 'drug addiction' is used now.  Drug addiction is a pattern of compulsive drug use characterized by overwhelming involvement with the use of a drug.  Amphetamines, cocaine, are CNS stimulants drugs which produce addiction but Little/no dependence.  Results : Feeling happy, Sexual arousal , fast heart beat , pupil dilation Ms. Kanchan chouksey
  • 27. Tachyphylaxis Ms. Kanchan chouksey  When some drugs administered repeatedly at short intervals, the cell receptors get blocked up and pharmacological response to that drug decreased.  The decreased response cannot be reversed by increasing the dose this phenomenon is called tachyphylaxis or acute tolerance  E.g. ephedrine given repeated dose at short intervals in the treatment of bronchial asthma may produce very less response due to tachyphylaxis
  • 28. Idiosyncrasy- Ms. Kanchan chouksey  Non-immunological hypersenstivity of drug in specific individual without connection to pharmacological toxicity.  Idiosyncrasy refers to genetically determined abnormal reactivity to a chemical.  Idiosyncrasy is also called as allergy.  An extraordinary response to a drug which is different from its characteristic pharmacological action is called idiosyncrasy.  E.g. small quantity of aspirin may cause gastric hemorrhage.  E.g. some persons are sensitive to penicillin and sulphonamide because they produce severe toxic effect.
  • 29. Drug allergy (hypersensitivity)  It is an immunologically mediated reaction.  The symptoms may appear even with much smaller doses and have a different time course of onset and duration.  This is also called drug hypersensitivity.  The target organs primarily affected in drug allergy are skin, airways, blood vessels, blood cells and gastrointestinal tract. Ms. Kanchan chouksey
  • 30. Continue…  The drug or its metabolite acts as an antigen (AG)  They induce production of antibody (AB)/sensitized lymphocytes.  A particular drug can produce different types of allergic reactions in different individuals, while widely different drugs can produce similar reaction.  Example : Penicillin causes anaphylaxis, methyldopa cause hemolytic anemia Ms. Kanchan chouksey
  • 32. Pharmacokinetics (The life cycle of a Drug)  Pharmacokinetics is the quantitative study of drug movement in, through and out of the body.  Pharmacokinetics: Pharmakon - drug and Kinesis - motion  The intensity of response is related to concentration of the drug at the site of action.  Pharmacokinetic - determine four pharmacokinetic properties determine the onset, intensity & duration of drug action. Ms. Kanchan chouksey
  • 35. Pharmacokinetics: Membrane Transport, Absorption and Distribution of Drugs All pharmacokinetic processes involve transport of the drug across biological membranes. Biological membrane: Ms. Kanchan chouksey
  • 36. Biological membrane: Ms. Kanchan chouksey  Biological membranes carry out functions that are indispensable for life.  They provide a barrier against the extracellular environment.  They also give shape to the cell, creating a matrix for insertion of proteins, storing and transmitting energy, receiving and amplifying signals,
  • 37. Structure of Biological membrane Composition: Ms. Kanchan chouksey
  • 38. Biological membrane Composition: Ms. Kanchan chouksey All Biological membrane are composed of mainly lipid and protein molecule: Three major types of lipids in cell membrane are:  Phospholipid -The most abundant.  Cholesterol- responsible for stabilizing the membrane.  Glycolipid- found at the external surface of the membrane.
  • 39. Membrane transport : Ms. Kanchan chouksey
  • 40. Membrane transport of drugs/nutrients : Ms. Kanchan chouksey
  • 41. Continue…  All of the lipids are described as being amphipathic as they have a hydrophilic (water- loving) end and a hydrophobic (water-hating) end to the molecule.  The proteins within the membrane are largely concerned with the transport of molecules across the membrane. Ms. Kanchan chouksey
  • 42. Continue… Drugs are transported across the membranes by: (a) Passive diffusion (b) filtration : for low molecular weight ( less than 100) (c) Specialized transport (d) Active transport Ms. Kanchan chouksey
  • 43. Passive diffusion:  The drug diffuses across the membrane in the direction of its concentration gradient (high to low).  The membrane playing no active role in the process.  This is the most important mechanism for majority o f drugs.  The drugs moves from high concentration to low concentration untill the equilibrium is maintained between extracellular and intracellular fluid  It does not require energy and depends on concentration. Ms. Kanchan chouksey
  • 46. Continue…  Lipid soluble drugs diffuse by dissolving in the lipoidal matrix of the membrane the rate of transport being proportional to the lipid  Water partition coefficient of the drug.  A more lipid-soluble drug attains higher concentration in the membrane and diffuses quickly.  Also, greater the difference in the concentration of the drug on the two sides of the membrane, faster is its diffusion. Ms. Kanchan chouksey
  • 47. Continue.. b) Filtration : for molecule of low molecular weight (less than 100) through 7 Å pores of membrane (1micrometer = 10000 Aangstrom) Example : Urea , ethylene glycol (additives) c) Bulk flow : Passage across capillary wall which pore size of 40Å. d)Active transport:  Require energy (ATP)  It work against concentration gradient ( Higher to lower concentration)  Example : Methyldopa, Levodopa e) Facilitated diffusion : through carrier proteins f) Endocystosis ( outside to inside) and exocytosis( Inside to outside) through pinocytosis, phagocytosis Ms. Kanchan chouksey
  • 48. Active transport : Ms. Kanchan chouksey
  • 50. Filtration  Filtration is passage of drugs through aqueous pores in the membrane or through paracellular spaces.  This can be accelerated if hydrodynamic flow of the solvent is occurring under hydrostatic or osmotic pressure gradient, e.g. across most capillaries including glomeruli. Ms. Kanchan chouksey
  • 51. Specialized transport  This can be carrier mediated or by vesicular transport.  Endocytosis & Exocytosis- Ms. Kanchan chouksey
  • 52. ABSORPTION  Absorption is the transfer of a drug from the site of administration to the bloodstream.  The rate and extent of absorption depend on the environment where the drug is absorbed, chemical characteristics of the drug, and the route of administration (which influences bioavailability).  Routes of administration other than intravenous may result in partial absorption and lower bioavailability Ms. Kanchan chouksey
  • 53. Factors influencing drug absorption:  Lipid solubility of drug  pH of the medium ( stomach & intestine)  pKa of the drug Ms. Kanchan chouksey
  • 54. Lipid solubility of the drug  Drugs which are lipophilic easily cross the membrane  Drugs which are lipophobic / Hydrophilic have problem crossing membrane  This is the major source of variation in drug diffusion or absorption  Only non ionized drug ( non-polar) diffuse across the cell membrane  Non polar drugs are lipid soluble  Polar drugs are water soluble , they cannot absorbs biological membrane  Lipid soluble = Non ionized molecule( NaCl)  Hydrophillic = Ionized molecule (Na+, Cl-) Ms. Kanchan chouksey
  • 55. Effect of pH on drug absorption : Ms. Kanchan chouksey  Acidic drug better absorbed in acidic media.  Basic drug better absorbed in basic media.  Acidic drugs ( aspirin) are better absorbed in stomach in acidic media.  Basic drugs better absorbed in intestine ( alkaline media).
  • 56. Bioavailability  Bioavailability is the rate and extent to which an administered drug reaches the systemic circulation.  Or Bioavailability is the rate and extent of drug absorbs from its dosage form that reach to the systemic circulation.  For example, if 100 mg of a drug is administered orally and 70 mg is absorbed unchanged, the bioavailability is 70%. Ms. Kanchan chouksey
  • 57. Objectives of Bioavailability studies: Ms. Kanchan chouksey  Primary stages of development of a suitable dosage form  Determination of influence of excipients (Stability and solubility) and interaction with other drugs on the efficiency of absorption
  • 59. First-pass hepatic metabolism:  When a drug is absorbed from the GI tract, it enters the portal circulation before entering the systemic circulation.  If the drug is rapidly metabolized in the liver or GIT wall during this initial passage, the amount of unchanged drug entering the systemic circulation is decreased.  This is referred to as first-pass metabolism.  Cytochrome P-450 enzymes metabolized many drugs. Ms. Kanchan chouksey
  • 61. Continue…  First-pass metabolism by the intestine or liver limits the efficacy of many oral medications.  For example, more than 90% of nitroglycerin (HF, HBP) is cleared during first-pass metabolism.  Hence, it is primarily administered via the sublingual or transdermal route  Drugs with high first-pass metabolism should be given in doses sufficient to ensure that enough active drug reaches the desired site of action. Ms. Kanchan chouksey
  • 62. DISTRIBUTION Drug distribution is the process by which a drug reversibly leaves the bloodstream and enters the extracellular fluid and the tissues. Phases of distribution: First phase :  Reflect cardiac output and blood flow –  Thus heart , liver, kidney, and brain receive most of the drugs during the first few minutes after absorption Second phase:  Deliver to muscle, skin, adipose is slower and involves a far large fraction of the body mass. Ms. Kanchan chouksey
  • 63. Drug reservoirs: Body compartment where a drug can accumulate are reservoirs and have dynamic effect on drug availability 1. Plasma proteins (albumins) as reservoirs (bind drug) 2. Cellular reservoirs:  Adipose (lipophillic drug)  Bone ( crystal ) Ms. Kanchan chouksey
  • 65. Drugs Binding primarily to albumin Ms. Kanchan chouksey  Barbiturates  Benzodiazepines  Digitoxin  Penicillins  Streptomycin  sulphonamindes
  • 66. Volume of distribution:  The volume of distribution Vd - is defined as the fluid volume that is required to contain the entire drug in the body at the same concentration measured in the plasma. Ms. Kanchan chouksey
  • 67. Volume of distribution : Ms. Kanchan chouksey
  • 68. Volume of distribution : Ms. Kanchan chouksey 100 mg water Vd= Amount of drug given in body / Concentration of drug in plasma Vd= 100/20= 5 L 20mg / L Concentration = Weight / volume ( mg / L)
  • 69. Ms. Kanchan chouksey  Drug metabolism is the term used to describe the biotransformation of pharmaceutical substances in the body so that they can be eliminated more easily.  It is the enzymatic conversion from one chemical form of a substance to another.  Metabolism is an essential pharmacokinetic process which converts lipid soluble or non-polar compounds to water soluble or polar compounds that they are excreted by various processes. Metabolism or Biotransformation:
  • 70. Phases of Metabolism  Phase I: Non-synthetic reactions such as cleavage (e.g. oxidation, reduction, hydrolysis), formation or modification of a function group.  Phase II: Synthetic reactions such as conjugation with an endogenous substance (e.g. sulfate, glycine, glucuronic acid). Examples:  Oxidation – phenytoin, barbiturates  Hydrolysis- Aspirin  Reduction- Benzodiazepines Ms. Kanchan chouksey
  • 71. Drug metabolism pathway : Ms. Kanchan chouksey
  • 73. Phase I and Phase II enzymes: Phase I enzymes:  Cytochrome P450, Esterase, Alcohol dehydrogenase ,Monoamine oxidase Phase II enzymes:  Uridine Diphosphate-glucuronosyl transferase (UDPGT) (Catalyse the covalent addition of glucuronic acid with lipophilic chemicals)  Sulfo transferase ( sulphonation increases water solublity of lipophilic drugs) Ms. Kanchan chouksey
  • 74. Metabolic enzyme: Ms. Kanchan chouksey Microsomal enzyme  Found in smooth endoplasmic reticulum of liver cells.  Example: CYP- 450, mono oxygenase Non- microsomal enzymes:  Found in cytoplasm and mitochondria of liver cells.  Example: Alcholol dehydrogenase,
  • 76. Drugs and their metabolites are excreted in: 1. Urine –  Drug excretion in urine occurs via the kidney.  It is the most important channel of excretion for majority of drugs. 2. Faeces –  Apart from the unabsorbed fraction, most of the drug present in faeces is derived from bile.  Liver actively transports into bile organic acids Ms. Kanchan chouksey
  • 77. Continue.. 3. Milk –  The excretion or drug in milk is not important for the mother.  Most drugs enter breast milk by passive diffusion.  As such. more lipid soluble and less protein bound drugs cross better.  Milk has a lower pH (7.0) than plasma, basic drugs are somewhat more concentrated in it. Ms. Kanchan chouksey
  • 78. Enzyme Inducers and Enzyme inhibitors : Ms. Kanchan chouksey
  • 79. Kinetics of drug metabolism and elimination: Ms. Kanchan chouksey
  • 82. Thank You Great God, Medi-Caps, All the attendees Ms. Kanchan chouksey Ms. Kanchan chouksey

Editor's Notes

  1. Title - Times new roman 38 pt, Name, Dept, Email - Times new roman 28
  2. Sample Slide
  3. Sample Slide